C109H153F3N22O13S2 — CID 167652386
2-ethyl-N-[(1S)-3-[4-[(2S,3R)-3-(ethylsulfonylamino)-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;2-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-[[2-(1-methylpiperidin-4-yl)pyrazole-3-carbonyl]amino]-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[4-[(3S)-3-[(2-ethylpyrazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1,2-thiazole-4-carboxamide (PubChem CID 167652386) has the molecular formula C109H153F3N22O13S2 and a molecular weight of 2100.69 g/mol. Its IUPAC name is 2-ethyl-N-[(1S)-3-[4-[(2S,3R)-3-(ethylsulfonylamino)-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;2-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-[[2-(1-methylpiperidin-4-yl)pyrazole-3-carbonyl]amino]-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[4-[(3S)-3-[(2-ethylpyrazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1,2-thiazole-4-carboxamide.
| Compound Name | 2-ethyl-N-[(1S)-3-[4-[(2S,3R)-3-(ethylsulfonylamino)-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;2-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-[[2-(1-methylpiperidin-4-yl)pyrazole-3-carbonyl]amino]-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[4-[(3S)-3-[(2-ethylpyrazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1,2-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 167652386 |
| Molecular Formula | C109H153F3N22O13S2 |
| Molecular Weight | 2100.69 g/mol |
| Exact Mass | 2099.14 |
| IUPAC Name | 2-ethyl-N-[(1S)-3-[4-[(2S,3R)-3-(ethylsulfonylamino)-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;2-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-[[2-(1-methylpiperidin-4-yl)pyrazole-3-carbonyl]amino]-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[4-[(3S)-3-[(2-ethylpyrazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1,2-thiazole-4-carboxamide |
| SMILES | CCn1nccc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)c2ccnn2C2CCN(C)CC2)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCn1nccc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)c2cnsc2)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCn1nccc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NS(=O)(=O)CC)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1 |
| InChI | InChI=1S/C41H58FN9O4.C35H46FN7O4S.C33H49FN6O5S/c1-6-50-34(13-17-43-50)39(53)46-38(29-9-7-27(2)8-10-29)36(52)26-31-12-11-30(25-33(31)42)28(3)37(41(55)49-23-21-48(5)22-24-49)45-40(54)35-14-18-44-51(35)32-15-19-47(4)20-16-32;1-5-43-29(12-13-37-43)34(46)40-32(24-8-6-22(2)7-9-24)30(44)19-26-11-10-25(18-28(26)36)23(3)31(39-33(45)27-20-38-48-21-27)35(47)42-16-14-41(4)15-17-42;1-6-40-28(14-15-35-40)32(42)36-31(24-10-8-22(3)9-11-24)29(41)21-26-13-12-25(20-27(26)34)23(4)30(37-46(44,45)7-2)33(43)39-18-16-38(5)17-19-39/h11-14,17-18,25,27-29,32,37-38H,6-10,15-16,19-24,26H2,1-5H3,(H,45,54)(H,46,53);10-13,18,20-24,31-32H,5-9,14-17,19H2,1-4H3,(H,39,45)(H,40,46);12-15,20,22-24,30-31,37H,6-11,16-19,21H2,1-5H3,(H,36,42)/t27?,28-,29?,37+,38-;22?,23-,24?,31+,32-;22?,23-,24?,30+,31-/m000/s1 |
| InChIKey | QTNAHMNXHGKDNE-JBDBUIIZSA-N |
| XLogP | 10.79 |
| TPSA | 400.94 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 149 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2100.69 |
| LogP ≤ 5 | 10.79 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 27 |